Sign in

You're signed outSign in or to get full access.

Lepercq de Neuflize Asset Management LLC

CIK:0001854423
Investment Adviser
$152M AUM
10 holdings
New York, NY, United States
Founded:2001
10 employees
Latest filing:Jun 30, 2025

Lepercq De Neuflize Asset Management LLC is an SEC-registered investment adviser headquartered in New York, NY, United States. The firm primarily serves institutional and high-net-worth clients and manages a portfolio of public securities and ETFs. As of June 2025, it reports approximately $151 million in portfolio holdings per 13F filings but may oversee a higher total AUM. The company is specialized in asset management and investment advisory services.

Investment Strategy

Lepercq De Neuflize Asset Management LLC invests primarily in public market securities with a focus on large, liquid ETFs such as SPDR S&P 500 ETF, iShares MSCI EAFE ETF, and selective positions in equities and options. The firm's approach tends toward strategic asset allocation and global diversification, leveraging index products and selective active bets to balance risk and returns. Holdings data and regulatory filings suggest a disciplined, transparent investment style favoring broad market exposure.

Latest 13F Filing Activity

Lepercq de Neuflize Asset Management LLC filed their most recent 13F report on Jun 30, 2025 disclosing 6 equity positions with a total 13F market value of $152M. The fund increased holdings in SPDR S&P 500 Etf TR, Ishares TR, Qorvo Inc. among other positions. Lepercq de Neuflize Asset Management LLC reduced exposure to Lifecore Biomedical Inc., Presidio PPTY TR Inc., Enzo Biochem Inc. among others.

Top Buys
S
SPYSPDR S&P 500 ETF TR
+$6.7M
E
EFAISHARES TR
+$3.6M
Q
QRVOQORVO INC
+$1.2M
C
CLARCLARUS CORP NEW
+$28.5K
L
LVTXLAVA THERAPEUTICS NV
+$11.7K
Top Sells
Q
QRVOQORVO INC
+$1.2M
L
LFCRLIFECORE BIOMEDICAL INC
-$138.7K
S
SQFTPRESIDIO PPTY TR INC
-$77.1K
E
ENZENZO BIOCHEM INC
-$57.8K
A
ANTXAN2 THERAPEUTICS INC
-$31.6K

Top Holdings

S
SPYSPDR S&P 500 ETF TR
+47.0%$71.2M
E
EFAISHARES TR
+27.5%$41.7M
Q
QRVOQORVO INC
+0.8%$1.2M
C
CLARCLARUS CORP NEW
+0.1%$111.7K
E
EPIXESSA PHARMA INC
+0.0%$57.3K

Equity Positions (6)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
SPDR S&P 500 ETF TR46.97%$71.2M115,245$586.08$617.85+$6.7M
ISHARES TR27.48%$41.7M466,000$75.61$89.39+$3.6M
QORVO INC0.77%$1.2M13,700$84.91$84.91+$1.2M
CLARUS CORP NEW0.07%$111.7K32,200$4.16$3.47+$28.5K
ESSA PHARMA INC0.04%$57.3K33,700$1.78$1.70+$7.2K

Industry Allocation

SEMICONDUCTORS & RELATED DEVICES
+2.8%
SPORTING & ATHLETIC GOODS, NEC
+0.1%
PHARMACEUTICAL PREPARATIONS
+0.0%